Lumentum (LITE - Free Report) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +6.80%. A quarter ago, it was expected that this optical networking products maker would post earnings of $0.82 per share when it actually produced earnings of $0.88, delivering a surprise of +7.32%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Lumentum, which belongs to the Zacks Communication - Components industry, posted revenues of $533.8 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.43%. This compares to year-ago revenues of $336.9 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Lumentum shares have added about 137.7% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Lumentum?While Lumentum has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Lumentum was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.15 on $559.74 million in revenues for the coming quarter and $4.90 on $2.3 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Communication - Components is currently in the top 13% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Altice USA, Inc. (ATUS - Free Report) , is yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This company is expected to post quarterly loss of $0.04 per share in its upcoming report, which represents a year-over-year change of +55.6%. The consensus EPS estimate for the quarter has been revised 9.1% higher over the last 30 days to the current level.
Altice USA, Inc.'s revenues are expected to be $2.14 billion, down 3.8% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
Innospec (IOSP) Tops Q3 Earnings and Revenue Estimates
Innospec (IOSP - Free Report) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.35 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +8.74%. A quarter ago, it was expected that this specialty chemicals company would post earnings of $1.17 per share when it actually produced earnings of $1.26, delivering a surprise of +7.69%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Innospec, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $441.9 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.73%. This compares to year-ago revenues of $443.4 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Innospec shares have lost about 33.1% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Innospec?While Innospec has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Innospec was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.37 on $479.2 million in revenues for the coming quarter and $5.08 on $1.8 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the bottom 9% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Chemours (CC - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This chemical company is expected to post quarterly earnings of $0.24 per share in its upcoming report, which represents a year-over-year change of -40%. The consensus EPS estimate for the quarter has been revised 33.3% lower over the last 30 days to the current level.
Chemours' revenues are expected to be $1.49 billion, down 0.6% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
Why Jabil (JBL) Dipped More Than Broader Market Today
Jabil (JBL - Free Report) closed at $209.22 in the latest trading session, marking a -5.03% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 1.17% for the day. Meanwhile, the Dow experienced a drop of 0.53%, and the technology-dominated Nasdaq saw a decrease of 2.04%.
The electronics manufacturer's shares have seen an increase of 8.96% over the last month, surpassing the Computer and Technology sector's gain of 5.49% and the S&P 500's gain of 2.12%.
Investors will be eagerly watching for the performance of Jabil in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $2.7, marking a 35% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $8.01 billion, indicating a 14.6% upward movement from the same quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $11.05 per share and revenue of $31.32 billion, indicating changes of +13.33% and +5.09%, respectively, compared to the previous year.
It is also important to note the recent changes to analyst estimates for Jabil. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. As of now, Jabil holds a Zacks Rank of #3 (Hold).
Looking at valuation, Jabil is presently trading at a Forward P/E ratio of 19.94. For comparison, its industry has an average Forward P/E of 20.08, which means Jabil is trading at a discount to the group.
It is also worth noting that JBL currently has a PEG ratio of 1.43. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Electronics - Manufacturing Services industry had an average PEG ratio of 1.37 as trading concluded yesterday.
The Electronics - Manufacturing Services industry is part of the Computer and Technology sector. This industry, currently bearing a Zacks Industry Rank of 96, finds itself in the top 39% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
InnovAge Holding Corp. (INNV) Q1 Earnings and Revenues Top Estimates
InnovAge Holding Corp. (INNV - Free Report) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +500.00%. A quarter ago, it was expected that this company would post a loss of $0.02 per share when it actually produced a loss of $0.01, delivering a surprise of +50%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
InnovAge, which belongs to the Zacks Medical Services industry, posted revenues of $236.11 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.01%. This compares to year-ago revenues of $205.14 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
InnovAge shares have added about 20.6% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for InnovAge?While InnovAge has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for InnovAge was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.04 on $228.02 million in revenues for the coming quarter and $0.24 on $925.64 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Services is currently in the bottom 43% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
AMN Healthcare Services (AMN - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This health care staffing company is expected to post quarterly earnings of $0.19 per share in its upcoming report, which represents a year-over-year change of -68.9%. The consensus EPS estimate for the quarter has been revised 25.5% lower over the last 30 days to the current level.
AMN Healthcare Services' revenues are expected to be $615.14 million, down 10.5% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
Why Samsara Inc. (IOT) Dipped More Than Broader Market Today
Samsara Inc. (IOT - Free Report) closed the most recent trading day at $38.72, moving -4.37% from the previous trading session. This move lagged the S&P 500's daily loss of 1.17%. On the other hand, the Dow registered a loss of 0.53%, and the technology-centric Nasdaq decreased by 2.04%.
Prior to today's trading, shares of the company had gained 1.02% lagged the Computer and Technology sector's gain of 5.49% and the S&P 500's gain of 2.12%.
The investment community will be closely monitoring the performance of Samsara Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on December 4, 2025. The company is forecasted to report an EPS of $0.12, showcasing a 71.43% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $399.44 million, up 24.06% from the year-ago period.
IOT's full-year Zacks Consensus Estimates are calling for earnings of $0.47 per share and revenue of $1.57 billion. These results would represent year-over-year changes of +80.77% and +33.45%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Samsara Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Samsara Inc. is currently a Zacks Rank #3 (Hold).
Looking at valuation, Samsara Inc. is presently trading at a Forward P/E ratio of 86.41. Its industry sports an average Forward P/E of 29.38, so one might conclude that Samsara Inc. is trading at a premium comparatively.
We can additionally observe that IOT currently boasts a PEG ratio of 1.98. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Internet - Software industry was having an average PEG ratio of 2.04.
The Internet - Software industry is part of the Computer and Technology sector. Currently, this industry holds a Zacks Industry Rank of 77, positioning it in the top 32% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
California Resources Corporation (CRC) Surpasses Q3 Earnings Estimates
California Resources Corporation (CRC - Free Report) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.5 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +11.45%. A quarter ago, it was expected that this company would post earnings of $0.91 per share when it actually produced earnings of $1.1, delivering a surprise of +20.88%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
California Resources, which belongs to the Zacks Oil and Gas - Exploration and Production - United States industry, posted revenues of $855 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 2.74%. This compares to year-ago revenues of $1.35 billion. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
California Resources shares have lost about 9.1% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for California Resources?While California Resources has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for California Resources was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.61 on $806.46 million in revenues for the coming quarter and $4.15 on $3.44 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Exploration and Production - United States is currently in the bottom 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, EOG Resources (EOG - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This oil and gas company is expected to post quarterly earnings of $2.43 per share in its upcoming report, which represents a year-over-year change of -15.9%. The consensus EPS estimate for the quarter has been revised 2.3% lower over the last 30 days to the current level.
EOG Resources' revenues are expected to be $5.95 billion, down 0.3% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
Astera Labs, Inc. (ALAB) Q3 Earnings and Revenues Top Estimates
Astera Labs, Inc. (ALAB - Free Report) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +25.64%. A quarter ago, it was expected that this company would post earnings of $0.33 per share when it actually produced earnings of $0.44, delivering a surprise of +33.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Astera Labs, Inc., which belongs to the Zacks Internet - Software industry, posted revenues of $230.58 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 11.53%. This compares to year-ago revenues of $113.09 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Astera Labs, Inc. shares have added about 44.6% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Astera Labs, Inc.?While Astera Labs, Inc. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Astera Labs, Inc. was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.42 on $217.39 million in revenues for the coming quarter and $1.58 on $775.49 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Procore Technologies (PCOR - Free Report) , is yet to report results for the quarter ended September 2025. The results are expected to be released on November 5.
This construction management software is expected to post quarterly earnings of $0.31 per share in its upcoming report, which represents a year-over-year change of +29.2%. The consensus EPS estimate for the quarter has been revised 92% higher over the last 30 days to the current level.
Procore Technologies' revenues are expected to be $327.44 million, up 10.7% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates
CareDx (CDNA - Free Report) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +115.38%. A quarter ago, it was expected that this molecular diagnostics company would post earnings of $0.12 per share when it actually produced earnings of $0.1, delivering a surprise of -16.67%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
CareDx, which belongs to the Zacks Medical Services industry, posted revenues of $100.06 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.07%. This compares to year-ago revenues of $82.88 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
CareDx shares have lost about 31% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for CareDx?While CareDx has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for CareDx was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.19 on $101.74 million in revenues for the coming quarter and $0.51 on $368.34 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Services is currently in the bottom 43% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Co-Diagnostics, Inc. (CODX - Free Report) , is yet to report results for the quarter ended September 2025. The results are expected to be released on November 13.
This company is expected to post quarterly loss of $0.19 per share in its upcoming report, which represents a year-over-year change of +40.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Co-Diagnostics, Inc.'s revenues are expected to be $0.3 million, down 53.1% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
Bitfarms Ltd. (BITF) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Bitfarms Ltd. (BITF - Free Report) closed at $3.84, marking a -6.57% move from the previous day. This change lagged the S&P 500's daily loss of 1.17%. On the other hand, the Dow registered a loss of 0.53%, and the technology-centric Nasdaq decreased by 2.04%.
Prior to today's trading, shares of the company had gained 18.79% outpaced the Business Services sector's loss of 5.24% and the S&P 500's gain of 2.12%.
The investment community will be closely monitoring the performance of Bitfarms Ltd. in its forthcoming earnings report. The company is scheduled to release its earnings on November 13, 2025. On that day, Bitfarms Ltd. is projected to report earnings of -$0.02 per share, which would represent year-over-year growth of 77.78%. Meanwhile, our latest consensus estimate is calling for revenue of $83.11 million, up 85.31% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$0.15 per share and a revenue of $314.54 million, representing changes of -7.14% and +63.07%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Bitfarms Ltd. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 16.67% downward. Bitfarms Ltd. is currently sporting a Zacks Rank of #4 (Sell).
The Technology Services industry is part of the Business Services sector. Currently, this industry holds a Zacks Industry Rank of 85, positioning it in the top 35% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
Corvus Pharmaceuticals, Inc. (CRVS) Q3 2025 Earnings Call Transcript
Corvus Pharmaceuticals, Inc. (CRVS) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST
Company Participants
Leiv Lea - Chief Financial Officer
Richard Miller - Co-Founder, President, CEO & Chairman of the Board
Conference Call Participants
Zack Kubow - Real Chemistry, Inc.
Graig Suvannavejh - Mizuho Securities USA LLC, Research Division
Jeffrey Jones - Oppenheimer & Co. Inc., Research Division
Li Wang Watsek - Cantor Fitzgerald & Co., Research Division
Aydin Huseynov - Ladenburg Thalmann & Co. Inc., Research Division
Jordan Becker - Barclays Bank PLC, Research Division
Xun Lee - H.C. Wainwright & Co, LLC, Research Division
Cha Cha Yang - Jefferies LLC, Research Division
Presentation
Operator
Good afternoon, everyone. Thank you for standing by, and welcome to the Corvus Pharmaceuticals Third Quarter 2025 Business Update and Financial Results Conference Call. [Operator Instructions]
It is now my pleasure to turn the call over to Zack Kubow of Real Chemistry. Please go ahead, sir.
Zack Kubow
Real Chemistry, Inc.
Thank you, operator, and good afternoon, everyone. Thanks for joining us for the Corvus Pharmaceuticals Third Quarter 2025 Business Update and Financial Results Conference Call.
On the call to discuss the results and business updates are Richard Miller, Chief Executive Officer; Leiv Lea, Chief Financial Officer; Jeff Arcara, Chief Business Officer; and Ben Jones, Senior Vice President of Regulatory and Pharmaceutical Sciences. The executive team will open the call with some prepared remarks, followed by a question-and-answer period.
I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by those statements, including the risks and uncertainties described in Corvus' quarterly report on Form 10-Q for the quarter ended September
Recommended For You
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
Adecoagro (AGRO) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Adecoagro (AGRO - Free Report) closed the most recent trading day at $7.64, moving -3.05% from the previous trading session. This move lagged the S&P 500's daily loss of 1.17%. Meanwhile, the Dow lost 0.53%, and the Nasdaq, a tech-heavy index, lost 2.04%.
The producer of agricultural products and renewable energy's stock has climbed by 0.9% in the past month, exceeding the Consumer Staples sector's loss of 2.36% and lagging the S&P 500's gain of 2.12%.
Market participants will be closely following the financial results of Adecoagro in its upcoming release.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $0.35 per share and a revenue of $1.35 billion, indicating changes of -82.67% and -11.27%, respectively, from the former year.
Investors should also take note of any recent adjustments to analyst estimates for Adecoagro. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 11.39% downward. Currently, Adecoagro is carrying a Zacks Rank of #4 (Sell).
In terms of valuation, Adecoagro is currently trading at a Forward P/E ratio of 22.51. This represents a premium compared to its industry average Forward P/E of 16.12.
The Agriculture - Operations industry is part of the Consumer Staples sector. Currently, this industry holds a Zacks Industry Rank of 210, positioning it in the bottom 15% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
2025-11-05 00:245mo ago
2025-11-04 19:165mo ago
Markets Stay Lower on Valuation Questions: AI, etc.
Key Takeaways Market Indexes Took a Break from New Daily GainsBoth AI and Crypto Trades Took Some Sandbags TodayQ3 Earnings After the Close Were Plentiful: ADM, AMGN, PINS, RIVN
Tuesday, November 4, 2025
It’s been a rougher trading week thus far, after notching all-time closing highs and leading to mixed results Monday. Today’s session was more assertive — to the down side. We’ve entered the rapid-pace phase of Q3 earnings season — after the Big Banks and most of the Mag 7, but before the Retailers — where results tend to come in more blended than they do for the earlier-reporting sectors.
None of the major indexes spent a split second trading in the green today. The Dow sold -251 points, -0.53% (and just over -1% in the past two trading days), while the S&P 500 sold -80 points, -1.17%. The tech-heavy Nasdaq led the major indexes downward, -486 points or -2.04%, while the small-cap Russell 2000 shed -43 points, -1.78%. The past five trading sessions have begun to illustrate something of a slide.
AI valuations had gotten a bit koo-koo, as most investors acknowledge. Several months in a row of throwing hundreds of billions of dollars in AI build-out across the major tech players, along with private upstart OpenAI, have led market participants to eye further developments in this vein with a bit more wariness. Same goes for crypto, which saw Bitcoin dip below $100K for a short time today.
Q3 Earnings After the Close: AMD, AMGN, RIVN & More
One of those tech firms vying for AI business is Advanced Micro Devices (AMD - Free Report) , which issued its Q3 results this afternoon with earnings of $1.20 per share — 3 cents above the Zacks consensus — on a strong revenue beat for the quarter: $9.25 billion versus $8.72 billion. Data Center business grew faster than expected, and revenue guidance was raised for Q4. That said, shares are trading down -2% after gaining over +100% year to date.
Biotech giant Amgen (AMGN - Free Report) easily outperformed expectations in its Q3 report this afternoon: earnings of $5.64 per share zoomed beyond the $5.00 analysts were looking for. Revenues of $9.56 billion surged past the $8.94 billion in the Zacks consensus. Full-year guidance is up on both top and bottom lines, as product sales grew +12% year over year.
EV company Rivian (RIVN - Free Report) posted a better-than-expected level of negative earnings in Q3, -$0.65 per share versus -$0.72 anticipated, and revenues of $1.56 billion outpaced the $1.46 billion in the Zacks consensus. Positive gross profit in three of the last four quarters on strength in sales for software and services have helped lead shares up +3.5% in late trading.
Super Micro Computer (SMCI - Free Report) came out with mixed results in its reported quarter this afternoon, beating on the bottom line to 35 cents per share from 28 cents projected. Revenues of $5.0 billion, on the other hand, was slightly short of the $5.05 billion analysts had predicted. The company said it sees a “rapidly expanding order book,” but this isn’t enough to stop the shares selling off -9% in the after hours.
Even worse is Pinterest (PINS - Free Report) , which logged its fourth-straight earnings miss, 38 cents per share versus 40 in the Zacks consensus, on just-met revenues of $1.05 billion in the quarter. Its now 600 million global active users is better than expected, but the company isn’t translating these into higher overall sales. Shares are down -18% after the close, swinging to a negative for the year to date so far.
Questions or comments about this article and/or author? Click here>>
Published in biotechnology earnings semiconductor tech-stocks
Essential Utilities (WTRG - Free Report) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +22.22%. A quarter ago, it was expected that this water utility would post earnings of $0.29 per share when it actually produced earnings of $0.38, delivering a surprise of +31.03%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Essential Utilities, which belongs to the Zacks Utility - Water Supply industry, posted revenues of $476.97 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.06%. This compares to year-ago revenues of $435.26 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Essential Utilities shares have added about 4.9% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Essential Utilities?While Essential Utilities has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Essential Utilities was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.42 on $598.76 million in revenues for the coming quarter and $2.10 on $2.37 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Utility - Water Supply is currently in the top 26% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, York Water (YORW - Free Report) , is yet to report results for the quarter ended September 2025.
This purifying and distribution company is expected to post quarterly earnings of $0.38 per share in its upcoming report, which represents a year-over-year change of -7.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
York Water's revenues are expected to be $21 million, up 6.5% from the year-ago quarter.
Lifevantage (LFVN - Free Report) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +5.88%. A quarter ago, it was expected that this dietary supplements and skin care products company would post earnings of $0.17 per share when it actually produced earnings of $0.17, delivering no surprise.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Lifevantage, which belongs to the Zacks Medical - Dental Supplies industry, posted revenues of $47.56 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 10.92%. This compares to year-ago revenues of $47.21 million. The company has not been able to beat consensus revenue estimates over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Lifevantage shares have lost about 58.1% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Lifevantage?While Lifevantage has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Lifevantage was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.22 on $57.83 million in revenues for the coming quarter and $1.05 on $232.54 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Dental Supplies is currently in the top 23% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, McKesson (MCK - Free Report) , is yet to report results for the quarter ended September 2025. The results are expected to be released on November 5.
This prescription drug distributor is expected to post quarterly earnings of $8.92 per share in its upcoming report, which represents a year-over-year change of +26.2%. The consensus EPS estimate for the quarter has been revised 0% lower over the last 30 days to the current level.
McKesson's revenues are expected to be $104.66 billion, up 11.8% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:215mo ago
Ovintiv (OVV) Q3 Earnings and Revenues Surpass Estimates
Ovintiv (OVV - Free Report) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $1.85 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +6.19%. A quarter ago, it was expected that this energy company would post earnings of $1.04 per share when it actually produced earnings of $1.02, delivering a surprise of -1.92%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Ovintiv, which belongs to the Zacks Oil and Gas - Exploration and Production - Canadian industry, posted revenues of $2.07 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 6.07%. This compares to year-ago revenues of $2.32 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Ovintiv shares have lost about 7.3% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Ovintiv?While Ovintiv has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Ovintiv was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.98 on $1.98 billion in revenues for the coming quarter and $4.36 on $8.62 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Exploration and Production - Canadian is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Canadian Natural Resources (CNQ - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This oil and natural gas company is expected to post quarterly earnings of $0.54 per share in its upcoming report, which represents a year-over-year change of -23.9%. The consensus EPS estimate for the quarter has been revised 8% higher over the last 30 days to the current level.
Canadian Natural Resources' revenues are expected to be $6.66 billion, up 2.2% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:215mo ago
NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates
NeuroPace, Inc. (NPCE - Free Report) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +45.00%. A quarter ago, it was expected that this company would post a loss of $0.24 per share when it actually produced a loss of $0.26, delivering a surprise of -8.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
NeuroPace, which belongs to the Zacks Medical - Instruments industry, posted revenues of $27.35 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 11.38%. This compares to year-ago revenues of $21.06 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
NeuroPace shares have lost about 16% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for NeuroPace?While NeuroPace has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for NeuroPace was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.18 on $25.44 million in revenues for the coming quarter and -$0.84 on $96.04 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Instruments is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Globus Medical (GMED - Free Report) , is yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This medical device company is expected to post quarterly earnings of $0.79 per share in its upcoming report, which represents a year-over-year change of -4.8%. The consensus EPS estimate for the quarter has been revised 1.3% lower over the last 30 days to the current level.
Globus Medical's revenues are expected to be $733.45 million, up 17.2% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:215mo ago
Montrose Environmental (MEG) Q3 Earnings and Revenues Top Estimates
Montrose Environmental (MEG - Free Report) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +9.09%. A quarter ago, it was expected that this company would post earnings of $0.25 per share when it actually produced earnings of $0.63, delivering a surprise of +152%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Montrose Environmental, which belongs to the Zacks Waste Removal Services industry, posted revenues of $224.89 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 14.83%. This compares to year-ago revenues of $178.69 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Montrose Environmental shares have added about 35.3% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Montrose Environmental?While Montrose Environmental has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Montrose Environmental was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.30 on $204.02 million in revenues for the coming quarter and $1.29 on $812.67 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Waste Removal Services is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
LanzaTech Global, Inc. (LNZA - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025.
This company is expected to post quarterly loss of $12.42 per share in its upcoming report, which represents a year-over-year change of +57.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
LanzaTech Global, Inc.'s revenues are expected to be $10.2 million, up 2.6% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:215mo ago
Sphere 3D Corp. (ANY) Reports Q3 Loss, Lags Revenue Estimates
Sphere 3D Corp. (ANY - Free Report) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -18.18%. A quarter ago, it was expected that this company would post a loss of $0.11 per share when it actually produced a loss of $0.1, delivering a surprise of +9.09%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Sphere 3D, which belongs to the Zacks Financial - Miscellaneous Services industry, posted revenues of $2.62 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 12.57%. This compares to year-ago revenues of $2.36 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Sphere 3D shares have lost about 28% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Sphere 3D?While Sphere 3D has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Sphere 3D was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.11 on $3.4 million in revenues for the coming quarter and -$0.47 on $12.2 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial - Miscellaneous Services is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Brookfield Asset Management (BAM - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 7.
This investment manager is expected to post quarterly earnings of $0.40 per share in its upcoming report, which represents a year-over-year change of +5.3%. The consensus EPS estimate for the quarter has been revised 3.5% lower over the last 30 days to the current level.
Brookfield Asset Management's revenues are expected to be $1.33 billion, up 9.9% from the year-ago quarter.
2025-11-05 00:245mo ago
2025-11-04 19:215mo ago
Kinross Gold (KGC) Beats Q3 Earnings and Revenue Estimates
Kinross Gold (KGC - Free Report) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.24 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +12.82%. A quarter ago, it was expected that this gold mining company would post earnings of $0.33 per share when it actually produced earnings of $0.44, delivering a surprise of +33.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Kinross Gold, which belongs to the Zacks Mining - Gold industry, posted revenues of $1.8 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 17.76%. This compares to year-ago revenues of $1.43 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Kinross Gold shares have added about 152.4% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Kinross Gold?While Kinross Gold has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Kinross Gold was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.32 on $1.48 billion in revenues for the coming quarter and $1.57 on $6.53 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Mining - Gold is currently in the top 7% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Barrick Mining (B - Free Report) , is yet to report results for the quarter ended September 2025. The results are expected to be released on November 10.
This gold and copper mining company is expected to post quarterly earnings of $0.57 per share in its upcoming report, which represents a year-over-year change of +83.9%. The consensus EPS estimate for the quarter has been revised 3.2% higher over the last 30 days to the current level.
Barrick Mining's revenues are expected to be $4.22 billion, up 25.4% from the year-ago quarter.
8x8 (EGHT - Free Report) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +28.57%. A quarter ago, it was expected that this telecommunications services company would post earnings of $0.08 per share when it actually produced earnings of $0.08, delivering no surprise.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
8x8, which belongs to the Zacks Internet - Software industry, posted revenues of $184.1 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.82%. This compares to year-ago revenues of $181 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
8x8 shares have lost about 30.3% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for 8x8?While 8x8 has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for 8x8 was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.08 on $177.24 million in revenues for the coming quarter and $0.30 on $713.67 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Ziff Davis (ZD - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This internet and cloud services company is expected to post quarterly earnings of $1.76 per share in its upcoming report, which represents a year-over-year change of +7.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Ziff Davis' revenues are expected to be $369.55 million, up 4.5% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:095mo ago
Australia includes Reddit, Kick in teen social media ban
Item 1 of 3 The Reddit app icon on a smartphone in this illustration taken October 27, 2025. REUTERS/Dado Ruvic/Illustration
[1/3]The Reddit app icon on a smartphone in this illustration taken October 27, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
SYDNEY, Nov 5 (Reuters) - Australia's internet watchdog on Wednesday widened its world-first teen social media ban to include Reddit
(RDDT.N), opens new tab and video live streaming platform Kick, and said more sites could be added if their main role was to enable online social interaction.
Australia will become the first country to fine social media firms up to A$49.5 million ($32 million) if they fail to take reasonable steps to block users aged under 16. The law will become effective from December 10.
Sign up here.
The eSafety Commissioner on Wednesday urged tech firms to continually assess whether they meet the definition of an 'age-restricted social media platform' when they introduce new features or their primary usage changes.Discord, GitHub, LEGO Play, Roblox (RBLX.N), opens new tab, Steam and Steam Chat, Google Classroom, Messenger, Meta Platforms' (META.O), opens new tab WhatsApp and YouTube Kids do not currently meet the criteria for an age-restricted social media platform, the regulator said.Facebook, Instagram, Snapchat (SNAP.N), opens new tab, Threads, TikTok, X, and Alphabet-owned (GOOGL.O), opens new tab YouTube have already been included in the list.There will not be a static list of companies that are age-restricted because of the fast-changing nature of technology, eSafety said.When new tech platforms emerge or existing ones change their purposes, eSafety said it may reassess those services."We will continue to take a whole of ecosystem approach, but we want to reinforce that just because a service is excluded, it does not mean it is absolutely safe," eSafety Commissioner Julie Inman Grant said in a statement.($1 = 1.5389 Australian dollars)Reporting by Renju Jose in Sydney; Editing by Lincoln Feast.
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2025-11-04 23:245mo ago
2025-11-04 18:105mo ago
Stride, Inc. (LRN) Plunges 49% as Platform Upgrade Fails, Triggering Hagens Berman Probe -- Hagens Berman
SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prominent shareholder rights law firm Hagens Berman is investigating Stride, Inc. (NYSE: LRN), the online education platform, for potential violations of the U.S. securities laws following a series of negative market events and serious fraud allegations that have seen the company's stock price plummet.
The firm urges investors in Stride who suffered significant losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Visit: www.hbsslaw.com/investor-fraud/lrn
Contact the Firm Now: [email protected]
844-916-0895
Platform Issues and Weak Guidance Trigger Sell-Off
Yesterday, Stride, a learning technology company, reported Q1 earnings. The company’s quarterly results were overshadowed by a significant operational issue and cautious guidance.
Platform Disruption: Stride disclosed that it experienced major issues implementing an upgraded platform over the summer. Management estimates these disruptions caused the company to miss between 10,000 and 15,000 enrollments—a substantial number given the company's total enrollment is currently 247,700.CEO's Comments: CEO James Rhyu addressed the problem directly, stating: “The implementations did not go as smoothly as we anticipated... This poor customer experience has resulted in some higher withdrawal and lower conversion rates than we expected.” Management has stated the company will fix the upgrade within a year.Weakened Forecast: The most significant concern for investors was Stride’s guidance for 2026, forecasting sales growth of only 5%. This is a stark slowdown from the company's annualized sales growth of 19% over the last five years and has prompted the market to take a sharply cautious stance.
Prior Fraud Allegations and Lawsuit
The investigation by Hagens Berman also follows an earlier news event that impacted the stock. On September 14, 2025, a report revealed that Gallup-McKinley had filed a complaint against Stride, alleging fraud, deceptive practices, and systemic legal violations that prioritized profits over student welfare.
The allegations in the complaint reportedly include:
Student Enrollment Inflation: Artificially boosting reported student enrollment figures by including "ghost students" who never officially started or had been absent for at least ten consecutive days.Teacher Ratios and Licensing: Intentionally increasing student-to-teacher ratios to inflate profit margins and employing a significant number of insufficiently licensed teachers.Market Manipulation: Allegedly utilizing unlawful business practices to deliberately lower overhead costs for the sole purpose of inflating the company’s stock values.
On this news, Stride’s stock price plunged $18.60, or 11%, in heavy trading.
Hagens Berman’s Investigation
Hagens Berman's investigation focuses on whether Stride may have intentionally misled investors about operational challenges and its business practices.
“A major platform disruption on top of existing fraud allegations regarding enrollment figures and teacher quality raises potential red flags for investors and are areas we are closely scrutinizing,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Stride and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »
If you’d like more information and answers to frequently asked questions about the Stride investigation, read more »
Whistleblowers: Persons with non-public information regarding Stride should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Contact:
Reed Kathrein, 844-916-0895
2025-11-04 23:245mo ago
2025-11-04 18:105mo ago
Rivian is focused on finding other sources of rare earth materials and magnets, says CEO RJ Scaringe
RJ Scaringe, Rivian CEO, joins 'Closing Bell Overtime' and CNBC's Phil LeBeau to talk quarterly results, rare earth materials, R2 production, and more.
2025-11-04 23:245mo ago
2025-11-04 18:115mo ago
Jack Henry's first-quarter profit climbs on strong bank tech demand
(JKHY.O), opens new tab reported about a 21% jump in first-quarter profit on Tuesday, helped by resilient demand for its banking technology services.
The Monett, Missouri-based company, which competes against Fiserv
(FI.N), opens new tab and FIS
(FIS.N), opens new tab, provides technology and payment processing services to financial institutions, mainly community banks and credit unions.
Sign up here.
Small- and mid-sized financial institutions tend to rely more heavily on banking technology providers like Jack Henry, unlike major players such as JPMorgan Chase
(JPM.N), opens new tab, which have invested billions in developing proprietary tech stacks.
Jack Henry's revenue jumped 7.3% to $644.7 million during the first quarter. Revenue from services and support increased 5.7%, while processing rose 9.7%.
Net income was at $144 million, or $1.97 per share, during the three months ended September 30, compared with $119.2 million, or $1.63 per share, a year earlier.
Bank tech stocks have weakened this year amid investor concerns over increased financial institution consolidation and competitive threats, analysts have said.
They see the selloff in bank tech stocks as an opportunity for investors, given their business models benefit from a large base of recurring revenue.
Jack Henry's shares were up more than 4% after the bell. They have slipped 13% so far this year.
The company expects fiscal 2026 revenue to be between $2.49 billion and $2.51 billion, compared with its prior forecast of $2.48 billion to $2.50 billion. It expects annual profit per share in the range of $6.38 and $6.49, compared with $6.32 to $6.44 projected earlier.
Reporting by Pritam Biswas and Arasu Kannagi Basil in Bengaluru; Editing by Shilpi Majumdar
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Axon Enterprise (AXON - Free Report) came out with quarterly earnings of $1.17 per share, missing the Zacks Consensus Estimate of $1.63 per share. This compares to earnings of $1.45 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -28.22%. A quarter ago, it was expected that this maker of stun guns and body cameras would post earnings of $1.54 per share when it actually produced earnings of $2.12, delivering a surprise of +37.66%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Axon, which belongs to the Zacks Aerospace - Defense Equipment industry, posted revenues of $710.64 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.58%. This compares to year-ago revenues of $544.27 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Axon shares have added about 21.8% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Axon?While Axon has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Axon was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.67 on $740.62 million in revenues for the coming quarter and $6.91 on $2.72 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Aerospace - Defense Equipment is currently in the bottom 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Moog (MOG.A - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on November 21.
This aerospace contractor is expected to post quarterly earnings of $2.24 per share in its upcoming report, which represents a year-over-year change of +3.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Moog's revenues are expected to be $964.02 million, up 5.1% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:115mo ago
Mirum Pharmaceuticals, Inc. (MIRM) Surpasses Q3 Earnings and Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM - Free Report) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.1 per share. This compares to a loss of $0.3 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +150.00%. A quarter ago, it was expected that this company would post a loss of $0.31 per share when it actually produced a loss of $0.12, delivering a surprise of +61.29%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Mirum Pharmaceuticals, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $133.01 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.85%. This compares to year-ago revenues of $90.38 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Mirum Pharmaceuticals shares have added about 71.3% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Mirum Pharmaceuticals?While Mirum Pharmaceuticals has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Mirum Pharmaceuticals was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.15 on $137.68 million in revenues for the coming quarter and -$0.67 on $508.94 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Monte Rosa Therapeutics (GLUE - Free Report) , has yet to report results for the quarter ended September 2025.
This biopharmaceutical company is expected to post quarterly loss of $0.39 per share in its upcoming report, which represents a year-over-year change of -34.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Monte Rosa Therapeutics' revenues are expected to be $7.77 million, down 15.7% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:115mo ago
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue Estimates
Day One Biopharmaceuticals, Inc. (DAWN - Free Report) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to earnings of $0.38 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +32.14%. A quarter ago, it was expected that this company would post a loss of $0.35 per share when it actually produced a loss of $0.29, delivering a surprise of +17.14%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Day One Biopharmaceuticals, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $39.8 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.75%. This compares to year-ago revenues of $93.76 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Day One Biopharmaceuticals shares have lost about 42.3% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Day One Biopharmaceuticals?While Day One Biopharmaceuticals has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Day One Biopharmaceuticals was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.26 on $42.15 million in revenues for the coming quarter and -$1.19 on $144.36 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Dianthus Therapeutics, Inc. (DNTH - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025.
This company is expected to post quarterly loss of $0.86 per share in its upcoming report, which represents a year-over-year change of -16.2%. The consensus EPS estimate for the quarter has been revised 0.6% lower over the last 30 days to the current level.
Dianthus Therapeutics, Inc.'s revenues are expected to be $0.66 million, down 69.8% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:125mo ago
First National Bank Alaska announces unaudited results for third quarter 2025
ANCHORAGE, Alaska, Nov. 04, 2025 (GLOBE NEWSWIRE) -- First National Bank Alaska’s (OTCQX:FBAK) net income for the third quarter of 2025 was $21.4 million, or $6.75 per share. This compares to a net income of $18.0 million, or $5.68 per share, for the same period in 2024.
“First National’s 2025 performance demonstrates strong quarterly growth in net income and continued momentum across our key performance ratios,” said First National Board Chair and CEO/President Betsy Lawer. “Teams across the bank focused on strategies that drove loan and deposit growth, improved noninterest income improvement, and kept operating expenses aligned with our customer and operational goals. Return on assets of 1.53% underscores our commitment to high performance amongst our national peer group.”
Total assets increased to $5.2 billion as of Sept. 30, representing a year-to-date increase of $246.2 million with customer deposit and repurchase agreement growth totaling $190.3 million year to date. Assets decreased $313.3 million compared to Sept. 30, 2024, following $590.0 million in borrowing repayments during the fourth quarter of 2024. Return on assets as increased to 1.53% as of Sept. 30, 2025 – thirty-eight basis points higher than the prior year – reflecting strong net income performance in 2025.
Loans totaled $2.6 billion as of Sept. 30, 2025, an increase of $145.1 million compared to Sept. 30, 2024. Nonperforming loans were $10.8 million, 0.42% of outstanding loans, an increase from Sept. 30, 2024 on nonaccrual loan activity. The third quarter provision for credit losses totaled $0.4 million, compared to a benefit of $0.4 million in third quarter 2024. The year-to-date provision for credit losses totaled $2.6 million on loan growth through Sept. 30, 2025, compared to $0.8 million as of the same date last year. The allowance for credit losses as of Sept. 30, 2025 totaled $20.1 million, or 0.78% of total loans.
Interest and fees on loans for the third quarter totaled $44.1 million, an increase of $2.2 million, 5.3% over $41.9 million for the third quarter of 2024. Interest income from investment securities decreased $6.6 million for quarter ending Sept. 30, 2025, compared to 2024. Investment income in 2025 does not include supplemental income earned in 2024 on the short-term tactical borrowings. Interest income to average earning assets increased to 4.74% compared to 4.51% for the same period in 2024.
Total interest expense for the third quarter was $12.2 million, a decrease of $9.2 million from $21.3 million compared to the third quarter of 2024, which included $7.7 million in interest on borrowed funds. Deposits and repurchase agreements totaled $4.6 billion as of Sept. 30, 2025, an increase of $237.4 million over the prior year. Corresponding interest expense declined by $1.6 million for the third quarter 2025 as compared to the same period in 2024. Interest expense to average earning assets decreased to ninety-eight basis points compared to 1.47% as of Sept. 30, 2024.
Net interest margin through Sept. 30, 2025 increased to 3.76% compared to 3.04% for Sept. 30, 2024, driven by improved yields on earning assets and effective cost of funds management.
Noninterest operating income for third quarter 2025 was $7.6 million, representing a 1.5% increase from $7.5 million compared to the third quarter of 2024. Noninterest expenses for the same period increased $0.9 million, or 3.4%, compared to the same period in 2024, primarily due to higher salaries and benefits resulting from increased health care costs.
The efficiency ratio for Sept. 30, 2025, was 49.52%, highlighting First National Bank Alaska’s ability to generate strong revenue while maintaining lower operating expenses than both Alaska and national peers.
Shareholders’ equity reached $567.7 million as of Sept. 30, 2025, compared to $527.9 million as of Sept. 30, 2024. This $51.2 million year-to-date increase was driven by retained net income and a reduction in unrealized losses in the securities portfolio. Return on equity improved to 14.13%, compared to 12.90% as of Sept. 30, 2024. Book value per share increased to $179.27, compared to $166.68 as of Sept. 30, 2024. The bank’s Tier 1 leverage capital ratio of 11.70% remains above well-capitalized standards.
ABOUT FIRST NATIONAL BANK ALASKA
Alaska’s community bank since 1922, First National Bank Alaska proudly meets the financial needs of Alaskans with ATMs and 28 locations in 19 communities throughout the state, and by providing banking services to meet their needs across the nation and around the world.
For more than a century, the bank has been committed to supporting the communities it serves. In 2024, for the eighth consecutive reporting period over a span of twenty-four years, First National received an Outstanding Community Reinvestment Act performance rating from the Office of the Comptroller of the Currency.
In 2025, Alaska Business readers voted First National “Best of Alaska Business” in the Best Place to Work category for the 10th year in a row, Best Bank/Credit Union for the fifth time, and Best Customer Service for the second year in a row. Forbes also selected First National as the sixth best bank on their America’s Best Banks list and one of the top two banks in the state, and Newsweek recognized the bank as one of the nation’s Best Regional Banks and Credit Unions. In 2025, First National was also voted “Best of Alaska” in the Anchorage Daily News awards, ranking as one of the top three in the Bank/Financial category for the seventh consecutive year. American Banker recognized the bank as a “Best Bank to Work For” in 2024, for the seventh year in a row.
First National Bank Alaska is a Member FDIC, Equal Housing Lender, and is recognized as a Minority Depository Institution by the Office of the Comptroller of the Currency, as it is majority-owned by women.
Contact Corporate Communications
907-777-3409
Financial Overview (Unaudited)Quarter Ended ($ in thousands) 9/30/20256/30/20253/31/202512/31/20249/30/2024Balance Sheet Total Assets$5,243,993 $4,923,803 $4,890,081 $4,997,767 $5,557,306 Total Securities$2,002,118 $1,859,645 $1,882,332 $1,928,625 $2,602,519 Total Loans$2,590,699 $2,591,713 $2,607,081 $2,469,935 $2,445,596 Total Deposits$3,808,022 $3,586,204 $3,580,147 $3,679,155 $3,728,181 Repurchase Agreements$804,589 $731,808 $716,908 $743,193 $647,043 Total Deposits and Repurchase Agreements$4,612,611 $4,318,012 $4,297,055 $4,422,348 $4,375,224 Total Borrowing under Federal Bank Credit Facilities$15,000 $15,000 $15,000 $15,000 $604,868 Unrealized Loss on Marketable Securities, Net of Tax$(31,296)$(40,193)$(49,465)$(62,985)$(52,020)Total Shareholders' Equity$567,724 $550,135 $535,148 $516,562 $527,864 Income Statement Interest and Fees on Loans$44,116 $43,212 $41,150 $41,273 $41,886 Interest and Dividends on Investment Securities$12,229 $10,818 $11,150 $17,392 $18,808 Interest on Cash and Cash Equivalents$4,381 $2,969 $3,563 $4,597 $3,727 Total Interest and Loan Fee Income$60,726 $56,999 $55,863 $63,262 $64,421 Total Interest Expense$12,155 $11,842 $11,956 $18,591 $21,319 Provision for Credit Losses$436 $631 $1,535 $(118)$(432)Total Noninterest Operating Income$7,596 $7,363 $6,910 $7,178 $7,487 Net Gains on Investment Securities$- $- $- $10 $- Total Noninterest Expense$26,802 $27,083 $25,334 $27,696 $25,928 Provision for Income Taxes$7,570 $6,423 $6,214 $4,350 $7,099 Net Income$21,359 $18,383 $17,734 $19,931 $17,994 Earnings per Common Share$6.75 $5.80 $5.60 $6.29 $5.68 Dividend per Common Share$4.00 $4.00 $4.00 $6.40 $3.20 Financial Measures Return on Assets 1.53% 1.46% 1.42% 1.22% 1.15%Return on Equity 14.13% 13.53% 13.49% 13.60% 12.90%Net Interest Margin 3.76% 3.69% 3.63% 3.12% 3.04%Interest Income to Average Earning Assets 4.74% 4.67% 4.61% 4.57% 4.51%Interest Expense to Average Earning Assets 0.98% 0.98% 0.98% 1.45% 1.47%Efficiency Ratio 49.52% 50.58% 49.70% 53.51% 53.59% Capital Shareholders' Equity/Total Assets 10.83% 11.17% 10.94% 10.34% 9.50%Tier 1 Leverage Ratio 11.70% 11.95% 11.72% 10.54% 10.39%Regulatory Well Capitalized Minimum Ratio - Tier 1 Leverage Ratio 5.00% 5.00% 5.00% 5.00% 5.00%Tier 1 (Core) Capital$599,020 $590,328 $584,613 $579,547 $579,884 Credit Quality Nonperforming Loans and OREO$10,847 $9,802 $4,243 $4,313 $4,186 Nonperforming Loans and OREO/Total Loans 0.42% 0.38% 0.16% 0.17% 0.17%Nonperforming Loans and OREO/Tier 1 Capital 1.81% 1.66% 0.73% 0.74% 0.72%Allowance for Loan Losses$20,100 $20,025 $19,500 $18,025 $18,550 Allowance for Loan Losses/Total Loans 0.78% 0.77% 0.75% 0.73% 0.76% Net interest margin, yields, and efficiency ratios are tax effected.
Financial measures are year-to-date.
Per common share amounts are not in thousands.
2025-11-04 23:245mo ago
2025-11-04 18:135mo ago
Wayfair Prices Offering of $700 Million Senior Secured Notes
, /PRNewswire/ -- Wayfair Inc. (NYSE: W) (the "Company," "we" or "Wayfair") today announced the pricing by its subsidiary, Wayfair LLC (the "Issuer"), of its private offering of $700 million in aggregate principal amount of 6.75% senior secured notes due 2032 (the "Notes"). The Notes will mature on November 15, 2032, unless earlier repurchased or redeemed in accordance with their terms. The Notes offering is expected to close on November 7, 2025, subject to customary closing conditions.
We intend to use the net proceeds from the Notes offering to purchase a portion of our outstanding 3.250% convertible senior notes due 2027 (the "2027 Notes") and 3.500% convertible senior notes due 2028 (the "2028 Notes") and for general corporate purposes, which may include repayment of other existing indebtedness. No assurance can be given as to how much, if any, of the 2027 Notes or 2028 Notes will be repurchased, the terms on which they will be repurchased or the timing of any such repurchases. If we purchase any of the 2027 or 2028 Notes, we expect that certain holders of the 2027 Notes or 2028 Notes that we purchase who have hedged their equity price risk with respect to such 2027 Notes or 2028 Notes will unwind all or part of their hedge positions by buying our Class A common stock or entering into or unwinding various derivative transactions with respect to our Class A common stock. As a result, any future purchases of 2027 Notes and 2028 Notes and the potential related market activities by holders of such repurchased 2027 Notes or 2028 Notes could increase (or reduce the size of any decrease in) the market price of our Class A common stock.
The Notes will be fully and unconditionally guaranteed, jointly and severally, on a senior secured basis by Wayfair and certain Wayfair domestic subsidiaries that guarantee the Issuer's senior secured revolving credit facility and existing senior secured notes. The Notes and related guarantees will be secured on a first-priority basis by liens on the same assets that secure the Issuer's senior secured revolving credit facility and existing senior secured notes.
The Notes and related guarantees have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A under the Securities Act and to non-U.S. persons in accordance with Regulation S under the Securities Act.
This press release is for informational purposes only and shall not constitute an offer to sell or a solicitation of an offer to buy any securities. Any offer of the Notes and related guarantees is not being made to any person in any jurisdiction in which the offer, solicitation or sale is unlawful. This press release also shall not constitute an offer to purchase, a solicitation of an offer to sell, or notice of redemption with respect to any of Wayfair's outstanding convertible notes.
About Wayfair
Wayfair is the destination for all things home, and we make it easy to create a home that is just right for you. Whether you're looking for that perfect piece or redesigning your entire space, Wayfair offers quality finds for every style and budget, and a seamless experience from inspiration to installation.
The Wayfair family of brands includes:
Wayfair: Every style. Every home.
AllModern: Modern made simple.
Birch Lane: Classic style for joyful living.
Joss & Main: The ultimate style edit for home.
Perigold: The destination for luxury home.
Wayfair Professional: A one-stop Pro shop.
Wayfair generated $12.2 billion in net revenue for the twelve months ended September 30, 2025 and is headquartered in Boston, Massachusetts with global operations.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal and state securities laws. All statements other than statements of historical fact contained in this press release are forward-looking statements, including statements regarding the terms of the Notes; the anticipated use of the net proceeds from the offering of the Notes; the expected closing of the Notes offering; expectations regarding the repayment of Wayfair's outstanding convertible notes; expectations regarding potential derivative unwinding transactions by the holders of the 2027 Notes and the 2028 Notes in connection with the issuance of the Notes; and the potential market impact, including to the trading price of Wayfair's Class A common stock, of such derivative unwinding transactions. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expects," "plans," "anticipates," "continues," "could," "intends," "goals," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or the negative of these terms or other similar expressions. Forward-looking statements are based on current expectations of future events. We cannot guarantee that any forward-looking statement will be accurate, although we believe that we have been reasonable in our expectations and assumptions. Investors should realize that if underlying assumptions prove inaccurate or that known or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. Investors are therefore cautioned not to place undue reliance on any forward-looking statements. We believe that these risks and uncertainties include, but are not limited to, risks relating to dilution and liability management exercises generally, risks relating to the consummation of the Notes offering, risks relating to the impact, including to the trading price of Wayfair's Class A common stock, of any associated derivative unwinding transactions, adverse macroeconomic conditions, including economic instability, changes in laws and regulations, and other governmental actions or policies, including those related to taxes and new or increased tariffs and the uncertainty surrounding potential changes in such laws and regulations or other potential governmental actions or policies, export controls, sustained higher interest rates and inflation, slower growth or the potential for recession, disruptions in the global supply chain and other conditions affecting the retail environment for products we sell, and other matters that influence consumer spending and preferences, as well as our ability to plan for and respond to the impact of these conditions; our ability to increase our net revenue per active customer; our ability to build and maintain strong brands; and our ability to expand our business and compete successfully, including risks relating to achieving the anticipated benefits of investments in our technology and systems, including generative AI. A further list and description of risks, uncertainties and other factors that could cause or contribute to differences in our future results include the cautionary statements herein and in our most recent Annual Report on Form 10-K and in our other filings and reports with the Securities and Exchange Commission. We qualify all of our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of the date of this press release and, except as required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events or otherwise.
Media Relations Contact:
Tara Lambropoulos
[email protected]
Investor Relations Contact:
Ryan Barney
[email protected]
NMI Holdings (NMIH - Free Report) came out with quarterly earnings of $1.21 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.15 per share a year ago. These figures are adjusted for non-recurring items.
A quarter ago, it was expected that this mortgage insurance company would post earnings of $1.16 per share when it actually produced earnings of $1.22, delivering a surprise of +5.17%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
NMI Holdings, which belongs to the Zacks Insurance - Property and Casualty industry, posted revenues of $178.68 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.28%. This compares to year-ago revenues of $166.09 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
NMI Holdings shares have added about 0.1% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for NMI Holdings?While NMI Holdings has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for NMI Holdings was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.22 on $176.73 million in revenues for the coming quarter and $4.92 on $698.45 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Insurance - Property and Casualty is currently in the top 27% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Allstate (ALL - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 5.
This insurer is expected to post quarterly earnings of $8.20 per share in its upcoming report, which represents a year-over-year change of +109.7%. The consensus EPS estimate for the quarter has been revised 6.8% higher over the last 30 days to the current level.
Allstate's revenues are expected to be $17.35 billion, up 5.9% from the year-ago quarter.
Ultragenyx (RARE - Free Report) came out with a quarterly loss of $1.81 per share versus the Zacks Consensus Estimate of a loss of $1.23. This compares to a loss of $1.4 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -47.15%. A quarter ago, it was expected that this biotechnology company would post a loss of $1.27 per share when it actually produced a loss of $1.17, delivering a surprise of +7.87%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Ultragenyx, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $159.93 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 4.55%. This compares to year-ago revenues of $139.49 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Ultragenyx shares have lost about 20.4% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Ultragenyx?While Ultragenyx has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Ultragenyx was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$1.17 on $182.02 million in revenues for the coming quarter and -$5.26 on $657.62 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Fortress Biotech (FBIO - Free Report) , is yet to report results for the quarter ended September 2025.
This biopharmaceutical company is expected to post quarterly loss of $0.43 per share in its upcoming report, which represents a year-over-year change of +43.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Fortress Biotech's revenues are expected to be $23.68 million, up 61.9% from the year-ago quarter.
Allegiant Travel (ALGT - Free Report) came out with a quarterly loss of $2.09 per share versus the Zacks Consensus Estimate of a loss of $1.84. This compares to a loss of $2.02 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -13.59%. A quarter ago, it was expected that this travel services company would post earnings of $0.83 per share when it actually produced earnings of $1.23, delivering a surprise of +48.19%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Allegiant Travel, which belongs to the Zacks Transportation - Airline industry, posted revenues of $561.93 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 3.18%. This compares to year-ago revenues of $562.2 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Allegiant Travel shares have lost about 34.2% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Allegiant Travel?While Allegiant Travel has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Allegiant Travel was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.35 on $644.31 million in revenues for the coming quarter and $2.75 on $2.61 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Transportation - Airline is currently in the bottom 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Air Canada (ACDVF - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025.
This company is expected to post quarterly earnings of $0.56 per share in its upcoming report, which represents a year-over-year change of -70.2%. The consensus EPS estimate for the quarter has been revised 14.9% lower over the last 30 days to the current level.
Air Canada's revenues are expected to be $4.17 billion, down 6.9% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:165mo ago
Arista Networks (ANET) Q3 Earnings and Revenues Beat Estimates
Arista Networks (ANET - Free Report) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +4.17%. A quarter ago, it was expected that this cloud networking company would post earnings of $0.65 per share when it actually produced earnings of $0.73, delivering a surprise of +12.31%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Arista Networks, which belongs to the Zacks Internet - Software industry, posted revenues of $2.31 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.11%. This compares to year-ago revenues of $1.81 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Arista Networks shares have added about 42.6% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Arista Networks?While Arista Networks has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Arista Networks was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.73 on $2.3 billion in revenues for the coming quarter and $2.82 on $8.78 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Block (XYZ - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This mobile payments services provider is expected to post quarterly earnings of $0.63 per share in its upcoming report, which represents a year-over-year change of -28.4%. The consensus EPS estimate for the quarter has been revised 1.4% lower over the last 30 days to the current level.
Block's revenues are expected to be $6.34 billion, up 6.1% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:165mo ago
Amgen (AMGN) Q3 Earnings and Revenues Beat Estimates
Amgen (AMGN - Free Report) came out with quarterly earnings of $5.64 per share, beating the Zacks Consensus Estimate of $5 per share. This compares to earnings of $5.58 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +12.80%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of $5.26 per share when it actually produced earnings of $6.02, delivering a surprise of +14.45%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Amgen, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $9.56 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 6.87%. This compares to year-ago revenues of $8.5 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Amgen shares have added about 13.7% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Amgen?While Amgen has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Amgen was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $5.14 on $9.38 billion in revenues for the coming quarter and $21.08 on $35.66 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Opus Genetics, Inc. (IRD - Free Report) , is yet to report results for the quarter ended September 2025.
This company is expected to post quarterly loss of $0.14 per share in its upcoming report, which represents a year-over-year change of +51.7%. The consensus EPS estimate for the quarter has been revised 4.6% lower over the last 30 days to the current level.
Opus Genetics, Inc.'s revenues are expected to be $2.77 million, down 28.6% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:165mo ago
Aflac (AFL) Q3 Earnings and Revenues Beat Estimates
Aflac (AFL - Free Report) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $1.8 per share. This compares to earnings of $2.16 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +38.33%. A quarter ago, it was expected that this insurer would post earnings of $1.71 per share when it actually produced earnings of $1.78, delivering a surprise of +4.09%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Aflac, which belongs to the Zacks Insurance - Accident and Health industry, posted revenues of $4.74 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.59%. This compares to year-ago revenues of $2.95 billion. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Aflac shares have added about 3.4% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Aflac?While Aflac has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Aflac was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.70 on $4.47 billion in revenues for the coming quarter and $6.91 on $17.81 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Insurance - Accident and Health is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Trupanion (TRUP - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This provider of medical insurance covering cats and dogs is expected to post quarterly earnings of $0.06 per share in its upcoming report, which represents a year-over-year change of +100%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Trupanion's revenues are expected to be $361.23 million, up 10.3% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:165mo ago
RideNow Group, Inc. (RDNW) Q3 2025 Earnings Call Transcript
RideNow Group, Inc. (RDNW) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST
Company Participants
Jerene Makia
Michael Quartieri - CEO, President & Chairman of the Board
Joshua Barsetti - Executive VP & CFO
Conference Call Participants
Eric Wold - Texas Capital Securities, Research Division
Craig Kennison - Robert W. Baird & Co. Incorporated, Research Division
Presentation
Operator
Greetings, and welcome to the RideNow Group, Inc. Third Quarter 2025 Earnings Call. [Operator Instructions] And as a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jerene Makia, VP of Finance. Please go ahead.
Jerene Makia
Thank you, operator. Good afternoon, everyone, and thank you for joining us for RideNow's Third Quarter 2025 Earnings Conference Call. Joining me on the call today are Michael Quartieri, RideNow's Chairman, Chief Executive Officer and President; and Joshua Barsetti, RideNow's Chief Financial Officer. Our Q3 results are detailed in the press release issued this afternoon and supplemental information will be available in our third quarter Form 10-Q once filed.
Before we begin, I would like to remind you that comments made by management during this conference call may contain forward-looking statements, including, but not limited to, RideNow's market opportunities and future financial results. All forward-looking statements involve risks and uncertainties, which could affect RideNow's actual results and cause actual results to differ materially from forward-looking statements made by or on behalf of RideNow.
A discussion of material risks and important factors that could affect our actual results can be found in our filings with the SEC, which are also available on our Investor Relations website and at sec.gov. This conference call also contains time-sensitive information that is accurate only as of the date of this live broadcast, Tuesday, November 4, 2025. RideNow assumes no obligation to revise or update any forward-looking statement, whether written or
Recommended For You
2025-11-04 23:245mo ago
2025-11-04 18:195mo ago
3 Potential Scenarios to Watch for in D-Wave's Earnings Report
Shares of quantum computing firm D-Wave Quantum Inc. NYSE: QBTS skyrocketed by 244% so far in 2025 on a great deal of hype and an even heftier volume of speculation. Though shares have cooled in the last month, dropping by about 5.5% in the 30 days leading to Nov. 3, investors have still jumped at hints of success for the firm—including rumors that the federal government may be considering taking equity positions in D-Wave and other quantum firms, for example, or news that the company made an important sale in Europe.
2025-11-04 23:245mo ago
2025-11-04 18:205mo ago
Nasdaq 100: Still Bullish, New Price Targets (Technical Analysis)
Analyst’s Disclosure:I/we have a beneficial long position in the shares of QQQ either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-11-04 23:245mo ago
2025-11-04 18:215mo ago
Trex (TREX) Misses Q3 Earnings and Revenue Estimates
Trex (TREX - Free Report) came out with quarterly earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.37 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -8.93%. A quarter ago, it was expected that this maker of fencing and decking products would post earnings of $0.72 per share when it actually produced earnings of $0.74, delivering a surprise of +2.78%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Trex, which belongs to the Zacks Building Products - Wood industry, posted revenues of $285.35 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 5.64%. This compares to year-ago revenues of $233.72 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Trex shares have lost about 30.6% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Trex?While Trex has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Trex was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.32 on $199.24 million in revenues for the coming quarter and $2.21 on $1.23 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Building Products - Wood is currently in the bottom 5% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Johnson Controls (JCI - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on November 5.
This diversified technology and industrial company is expected to post quarterly earnings of $1.20 per share in its upcoming report, which represents a year-over-year change of -6.3%. The consensus EPS estimate for the quarter has been revised 1% higher over the last 30 days to the current level.
Johnson Controls' revenues are expected to be $6.32 billion, up 1.2% from the year-ago quarter.
Pinterest (PINS - Free Report) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.4 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -5.00%. A quarter ago, it was expected that this digital pinboard and shopping tool company would post earnings of $0.34 per share when it actually produced earnings of $0.33, delivering a surprise of -2.94%.
Over the last four quarters, the company has not been able to surpass consensus EPS estimates.
Pinterest, which belongs to the Zacks Internet - Software industry, posted revenues of $1.05 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.17%. This compares to year-ago revenues of $898.37 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Pinterest shares have added about 16.2% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Pinterest?While Pinterest has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Pinterest was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.71 on $1.33 billion in revenues for the coming quarter and $1.68 on $4.23 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Five9 (FIVN - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This provider of cloud-based software to call centers is expected to post quarterly earnings of $0.73 per share in its upcoming report, which represents a year-over-year change of +9%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Five9's revenues are expected to be $284.54 million, up 7.7% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:215mo ago
Supernus Pharmaceuticals (SUPN) Surpasses Q3 Earnings and Revenue Estimates
Supernus Pharmaceuticals (SUPN - Free Report) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $1.06 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +23.17%. A quarter ago, it was expected that this drugmaker would post earnings of $0.47 per share when it actually produced earnings of $0.91, delivering a surprise of +93.62%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Supernus, which belongs to the Zacks Medical - Generic Drugs industry, posted revenues of $192.1 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.52%. This compares to year-ago revenues of $175.69 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Supernus shares have added about 54% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Supernus?While Supernus has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Supernus was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.62 on $208 million in revenues for the coming quarter and $2.65 on $705.3 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Generic Drugs is currently in the top 18% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Assembly Biosciences (ASMB - Free Report) , is yet to report results for the quarter ended September 2025.
This biotech drug developer is expected to post quarterly loss of $0.50 per share in its upcoming report, which represents a year-over-year change of +66.9%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Assembly Biosciences' revenues are expected to be $10.2 million, up 49.1% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:215mo ago
Super Micro Computer (SMCI) Tops Q1 Earnings Estimates
Super Micro Computer (SMCI - Free Report) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.75 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +25.00%. A quarter ago, it was expected that this server technology company would post earnings of $0.44 per share when it actually produced earnings of $0.41, delivering a surprise of -6.82%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Super Micro, which belongs to the Zacks Computer- Storage Devices industry, posted revenues of $5.02 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.56%. This compares to year-ago revenues of $5.94 billion. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Super Micro shares have added about 66.5% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Super Micro?While Super Micro has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Super Micro was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.63 on $8.3 billion in revenues for the coming quarter and $2.54 on $34.13 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computer- Storage Devices is currently in the top 17% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Pure Storage (PSTG - Free Report) , another stock in the same industry, has yet to report results for the quarter ended October 2025.
This data storage company is expected to post quarterly earnings of $0.59 per share in its upcoming report, which represents a year-over-year change of +18%. The consensus EPS estimate for the quarter has been revised 1.7% higher over the last 30 days to the current level.
Pure Storage's revenues are expected to be $956.49 million, up 15.1% from the year-ago quarter.
AudioEye (AEYE - Free Report) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +5.56%. A quarter ago, it was expected that this company would post earnings of $0.16 per share when it actually produced earnings of $0.15, delivering a surprise of -6.25%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
AudioEye, which belongs to the Zacks Internet - Software industry, posted revenues of $10.23 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.22%. This compares to year-ago revenues of $8.93 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
AudioEye shares have added about 0.3% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for AudioEye?While AudioEye has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for AudioEye was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.22 on $10.63 million in revenues for the coming quarter and $0.70 on $40.47 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Fastly (FSLY - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on November 5.
This cloud software developer is expected to post quarterly earnings of $0.00 per share in its upcoming report, which represents a year-over-year change of -100%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Fastly's revenues are expected to be $151.52 million, up 10.4% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:215mo ago
Live Nation (LYV) Q3 Earnings and Revenues Lag Estimates
Live Nation (LYV - Free Report) came out with quarterly earnings of $0.73 per share, missing the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $1.66 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -39.67%. A quarter ago, it was expected that this ticket seller and concert promoter would post earnings of $1.01 per share when it actually produced earnings of $0.41, delivering a surprise of -59.41%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Live Nation, which belongs to the Zacks Film and Television Production and Distribution industry, posted revenues of $8.5 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.59%. This compares to year-ago revenues of $7.65 billion. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Live Nation shares have added about 15.7% since the beginning of the year versus the S&P 500's gain of 16.5%.
What's Next for Live Nation?While Live Nation has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Live Nation was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.93 on $6.49 billion in revenues for the coming quarter and $0.41 on $25.45 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Film and Television Production and Distribution is currently in the bottom 14% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
News Corp. (NWSA - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.
This publishing company whose flagship is The Wall Street Journal is expected to post quarterly earnings of $0.18 per share in its upcoming report, which represents a year-over-year change of -14.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
News Corp.'s revenues are expected to be $2.11 billion, down 18.1% from the year-ago quarter.
2025-11-04 23:245mo ago
2025-11-04 18:225mo ago
UPS plane crashes after taking off from Louisville airport
A UPS plane crashed on Tuesday around 5:15 p.m. local time after departing from Louisville Muhammad Ali International Airport in Kentucky, the Federal Aviation Administration said.
UPS said in a statement that there were three crewmembers onboard. "At this time, we have not confirmed any injuries/casualties," the company said.
The FAA said the plane was en route to Honolulu and that it and the National Transportation Safety Board would investigate the incident.
The Louisville Metro Police Department said on X that a shelter-in-place order had been issued for all locations within 5 miles of the airport.
Kentucky Gov. Andy Beshear said "the situation is serious" on X and that he was headed to Louisville.
This is breaking news. Please refresh for more details.
2025-11-04 22:245mo ago
2025-11-04 16:005mo ago
Bitcoin Liquidity Grabs: Institutions Target Low-Volume Zones To Move BTC Price
In the dynamic and often opaque world of Bitcoin trading, institutional traders are operating with a fundamentally different playbook. These players are actively hunting for low-volume areas and under-traded levels, seeing them as strategic advantages for maximizing profit.
Why Institutions Avoid The Crowd And Target The Gaps
Bitcoin’s institutional traders and big players are actively hunting low-volume areas. These zones are thinly traded areas, which shows that there are fewer resting orders, making it easier to fill massive positions with less slippage. In an X post, a crypto analyst known as Killa has stated that throughout this entire rally, players have hunted Low Volume Nodes (LVNs), or in simpler terms, the volume areas are lows every single time.
The reason for this accumulation is that if the BTC price is stalling, volume is increasing, and BTC is unable to follow through with bullish momentum, it shows that 75% of the time, the market is preparing to retrace to lower areas of demand. This is simple basic supply and demand dynamics playing out.
Source: Chart from Killa on X
However, there has been a major increase in volume around these highs, coupled with the multiple sweeps of liquidity above them. Despite what might seem like bullish tariff catalysts, the market has failed to push higher. If this combination happens, it could be a sign of distribution rather than re-accumulation of the trend.
Furthermore, if BTC can’t decisively reclaim the $114,000 monthly open, then the next logical target points downwards to the Volume Area Low (VAL) below $100,000. Should BTC push below $100,000 and manage to reclaim the VAL, then this will be a deviation into expansion, which is a reclaim of the range. On the other hand, if BTC is unable to reclaim the VAL after testing below $100,000, it would point to a bear market towards $50,000 to $60,000 range.
October Leverage Bloodbath Is Still Echoing
A popular crypto news source, CryptosRus, has mentioned that Bloomberg has dropped a report that the October liquidation shocks are still haunting crypto. Meanwhile, Bitcoin is back near $107,000, but the reason is not new Fear, Uncertainty, and Doubt (FUD) or macro pressure, but because traders are still shaken from the October wipeout.
The liquidation flushed billions in leverage, which is the biggest clean-out this market has seen in years. This drained confidence and completely sidelined buyers who still haven’t stepped back into the arena with conviction. Bloomberg says that the October shock absolutely repelled new demand, even as global risk assets continue to rally. Presently, the fundamentals for BTC are actually fine, but the sentiment is shell-shocked. According to CryptorRus, this is not a weakness, but it’s a recovery mode.
BTC trading at $104,216 on the 1D chart | Source: BTCUSDT on Tradingview.com
Featured image from Pixabay, chart from Tradingview.com
2025-11-04 22:245mo ago
2025-11-04 16:005mo ago
Dogecoin – Here's why another 20% price correction may be next
Key Takeaways
Why did Dogecoin experience a sharp price drop?
Over the past 24 hours, DOGE has fallen 5.2% and lost the apparent safety of the $0.18 support level, following Bitcoin’s correction to $104.1k.
Where could the current bearish move end?
The next support levels for Dogecoin are at $0.15 and $0.13, but traders should be prepared for a deeper correction if BTC loses the psychological $100k level.
Dogecoin [DOGE] whales bought 15.1 million DOGE, worth $2.9 million, last week. However, retail participants were selling at the same time, and the $0.2 resistance level remained resilient.
In a recent report, AMBCrypto observed that DOGE was trading at a vital support level, but faced overwhelming selling pressure. The OBV had dropped substantially, reflecting overwhelming selling, and the buyers were barely holding on.
The Bitcoin [BTC] volatility on the 3rd of November that took prices below the $108k level sent Dogecoin reeling.
At the time of writing, the leading memecoin was trading at $0.161, losing the $0.18 demand zone.
Of course, Bitcoin’s decline toward $100k extended losses across the entire market. How much further will DOGE fall?
The OBV illuminates the upcoming Dogecoin trends
Source: DOGE/USDT on TradingView
The 1-day timeframe showed that the Dogecoin bulls had a tenuous grip on the $0.18 support zone. In fact, the most recent Bitcoin correction tipped DOGE prices over the edge.
Such a move was predictable based on the OBV.
The OBV made a new low in the second week of October, falling lower than it had reached in the previous three months. This was an early sign that the bulls had lost the battle.
On top of that, the Awesome Oscillator also formed a bearish crossover to indicate downward momentum following the 10/10 crash.
There was no fightback from the buyers. Instead, selling pressure and fear continued to lead the way, finally sending DOGE below $0.18.
Liquidation data points to further downside
Meanwhile, CoinGlass’ Liquidation Heatmap showed that, over the past week, the price had fallen lower, reaching the long liquidations.
Dogecoin hovered at a price level, building up liquidity overhead before tagging it and dropping lower. Examples were the price action on the 28th-29th of October and the 1st-2nd of November.
If this latest pattern is to repeat, DOGE could climb toward the $0.172 pocket, meander just below it for a couple of days, briefly test it, and fall lower once again. The pattern might not play out again, but it is something traders can watch out for.
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion
Akashnath S is a Senior Journalist and Technical Analysis expert at AMBCrypto. He specializes in dissecting price action, identifying key market trends through advanced chart patterns, and forecasting both short-term and long-term asset trajectories.
His distinct analytical method is grounded in his academic training as a Chemical Engineer. This background provides him with a systematic, process-oriented approach to market data, enabling him to analyze the complex dynamics of financial markets with precision and objectivity.
Having actively covered the cryptocurrency space since the landmark 2017 market cycle, Akashnath possesses years of experience navigating both bull and bear markets. This seasoned perspective is critical to his insightful reporting on market volatility and evolution.
As an active market participant, Akashnath enhances his analysis with crucial, hands-on experience. This practical application of his technical skills ensures his insights are not merely theoretical, but are also relevant and actionable for an audience looking to understand and navigate trading opportunities. He is dedicated to educating readers on the nuances of technical analysis, empowering them with the knowledge to make more informed financial decisions.
2025-11-04 22:245mo ago
2025-11-04 16:085mo ago
MARA and Hut 8 profits surge in Q3 as Bitcoin reserves grow
Bitcoin miners MARA Holdings and Hut 8 posted strong third-quarter results on Tuesday, with both reporting sharply higher profits and expanding Bitcoin reserves.
MARA’s revenue climbed 92% year-over-year to $252 million in the third quarter of 2025, swinging from a $125 million loss to $123 million in net income over the period, while Hut 8’s revenue nearly doubled to $83.5 million with profits of $50.6 million.
Both miners also strengthened their balance sheets. MARA Holdings ended the quarter with 52,850 Bitcoin (BTC), nearly doubling its reserves from 26,747 BTC a year earlier. Hut 8 reported 13,696 BTC in its strategic reserve, up from 9,106 BTC in the same period last year.
The results highlight both companies’ continued diversification beyond Bitcoin mining into large-scale compute and energy infrastructure. MARA described itself as a “digital energy and infrastructure” company focused on converting excess energy into digital capital, including investments in low-carbon AI data centers through its $168 million acquisition of Exaion, a subsidiary of France’s state-owned utility EDF.
Hut 8 is pursuing a similar path, with 1.02 gigawatts of capacity under management and plans to expand to more than 2.5 gigawatts across North America as it builds out high-performance computing sites to serve both Bitcoin and AI workloads.
The results appeared to fall short of investor expectations, with both stocks trading lower on Tuesday. Hut 8 shares traded down about 9%, while MARA slides 5% at this writing.
Bitcoin traded near $99,000, down roughly 6% over the past 24 hours, according to Cointelegraph Markets Pro.
Source: Yahoo NewsThe US leads in Bitcoin miningFollowing China’s 2021 Bitcoin mining ban, much of the industry’s hash power migrated to the US, which now accounts for an estimated 37% of global Bitcoin hashrate, making it the single largest mining hub in the world. Six of the world’s ten largest publicly traded mining companies are based in the US.
Bitcoin hashrate by country. Source: World Population ReviewTexas has emerged as the leading state for US Bitcoin mining, offering cheap electricity, abundant renewable power, and a business-friendly power grid. Major miners, including MARA, Riot Platforms, CleanSpark, Bitdeer, and Hut 8, operate there, and it has even been called “an oasis for Bitcoin” by US Senator Ted Cruz.
Top 10 Bitcoin miners by market cap. Source: CompaniesMarketCapMeanwhile, some states are still debating how to regulate the sector. In New Hampshire, the Senate Commerce Committee deadlocked Friday on a bill to ease restrictions on crypto mining, following a surge in public feedback since the measure was last discussed.
Magazine: China officially hates stablecoins, DBS trades Bitcoin options: Asia Express
2025-11-04 22:245mo ago
2025-11-04 16:095mo ago
Berachain's Emergency Hard Fork Traps Hacker, Freezing Funds From Balancer V2 Exploit
Berachain has executed an emergency hard fork following the Balancer V2 exploit, pausing liveness as validators have upgraded and core partners prepare for reconnection. A white-hat MEV operator has agreed to return compromised funds to the Berachain deployer.
2025-11-04 22:245mo ago
2025-11-04 16:135mo ago
A Defining Moment for Bitcoin Art at Sotheby's: Tad Smith on Bitcoin Culture and Robert Alice's Block 1
This month, a remarkable Bitcoin-focused artwork will grace one of the art world’s most prestigious stages. Block 1 from Robert Alice’s Portraits of a Mind series is set to be auctioned in Sotheby’s Now & Contemporary Evening Sale on November 18, carrying an estimate of $600,000 to $800,000.
Robert Alice, Portraits of a Mind, 2019. Credit: Theo Cristelis
This event is where marquee works by renowned artists like Yves Klein or Jean-Michel Basquiat appear, so the inclusion of Block 1 signals an important moment for Bitcoin’s cultural presence. The auction will be held at The Breuer Building — once the home of the Whitney Museum of American Art and now Sotheby’s new worldwide headquarter in New York. It marks the first time a physical artifact of Bitcoin’s history stands alongside blue-chip artworks in such a high-profile sale.
In preparing this text, I spoke with Tad Smith, the former CEO of Sotheby’s and a thoughtful Bitcoiner, about the upcoming sale and what it means for Bitcoin’s cultural standing. Speaking as an archivist and art historian, I found our conversation becoming a meditation on value: how art and Bitcoin both rely on scarcity, story, and shared belief rather than financial metrics alone. Some of his remarks are included throughout this piece. His own path –– from auction house executive to Bitcoiner –– reflects the shift he describes: from assigning value within institutions to seeing value take shape through collective consensus.
Why does this matter? For years, Bitcoin has been understood primarily as a monetary revolution or a technical breakthrough. But Bitcoin is also an emerging cultural phenomenon, lacking obvious forums for recognition in mainstream culture. When a work like Block 10 (52.5243° N, -0.4362° E) from Alice’s series enters major collections like the Centre Pompidou –– one of Europe’s foremost museums of modern art –– it externalizes Bitcoin’s cultural value by translating intangible ethos into the language of art. I will return to this later. It is a clear sign that Bitcoin’s story is seeping into broader cultural memory, validated by institutions that historically canonize what matters in art and culture.
Block 1: The Code That Became Art
Formally and conceptually, Block 1 is steeped in Bitcoin’s origin story. Robert Alice’s Portraits of a Mind series took the original Bitcoin codebase (version 0.1.0) — arguably one of the most consequential texts of the 21st century — and dispersed it into 40 large-format paintings. In doing so, the project formed a decentralized, physical archive of Satoshi Nakamoto’s code with hundreds of thousands of hexadecimal digits distributed across the series.
Robert Alice, Detail of Portraits of a Mind, 2019. Credit: Theo Cristelis
Each painting in the series carries a set of geographical coordinates that tie fragments of Bitcoin’s code to places of human culture and memory. Block 1 (24.9472° N, 118.5979° E) points to the Statue of Laozi in Quanzhou, a place where philosophy and exchange have quietly coexisted for centuries — near a city that once marked an important point along the Silk Road. The choice of site draws a subtle line between Taoist thought and the libertarian ethos that runs through Bitcoin: Laozi’s idea of wu wei –– governing through non-interference –– echoes the blockchain’s own preference for order without rulers.
Tad Smith has called the series a memorial to the foundations of digital sovereignty — a body of work that captures the moment Bitcoin began to take form.
A decentered form runs through the series, echoing rai stones and allusions to Japanese currency. The work engages with themes of decentralization, code as text, code as portrait and the nature of memory. Influenced by conceptual and minimalist art (artists like Roman Opalka and Jasper Johns come to mind), Portraits of a Mind treats the Bitcoin codebase as cultural heritage, as something to be preserved and contemplated. The series makes something hidden, visible: it translates the code –– the true first text of Bitcoin, written even before the whitepaper –– into material form. On November 9, 2008, Satoshi wrote to Hal Finney: “I actually did this kind of backwards. I had to write all the code before I could convince myself that I could solve every problem, then I wrote the paper”. And Alice asks us to see code not just as functional instruction but as a foundational human document.
Since its debut, Portraits of a Mind has traveled in ways that mirror the network it was born from. Parts of the series have been shown in London, Hong Kong, and New York, as well as at Sealand — the self-declared cypherpunk micronation, once an illegal data haven for irregulated internet traffic. Works from the series have also appeared in museums across the world in Zurich, Seoul, Beijing, Hanover and Linz. In 2023, the series was shown at Monnaie de Paris, the world’s oldest continually running mint, further extending its reach into the contemporary art world.
Robert Alice’s exhibition of Portraits of a Mind at Sealand, the former cypher punk data haven in the North Sea in 2021. Credit: Robert Alice
Major auction houses like Sotheby’s and Christie’s play a pivotal role in validating new artistic movements. For blockchain-based art, that validation began in 2020 when Portraits of a Mind first made waves: one of its panels, Block 21 (42.36433° N, -71.26189° E), was the first Bitcoin-focused artwork to sell at a premier auction house and laid the foundation for the crypto art explosion, pre-dating the Beeple NFT sensation by six months and back then reached around $130,000. With Block 1 joining Sotheby’s Contemporary Evening Auction in New York, Bitcoin art reaches a new level of visibility. “In the evening sale [this piece] will further increase the reputation” of the series, Tad Smith noted, emphasizing how Sotheby’s platform brings tremendous publicity and cultural cachet. Indeed, a high result at Sotheby’s would broadcast the message that Bitcoin’s codebase is now an important cultural fixture to the narrative of the 21st century, rather than a niche plaything for tech enthusiasts.
Bitcoin’s Cultural Maturation
What does Block 1 at Sotheby’s tell us about Bitcoin’s own cultural maturation? For one, it underscores that Bitcoin’s impact isn’t measured only in market cap or hash rate — it’s also measured in cultural capital. Bitcoin has spawned ideas, values, and aesthetics, yet the protocol itself can’t record those human elements. There’s a lack of on-chain metrics for culture: the blockchain timestamps transactions, but not, say, the moment a Bitcoin artwork hangs in a museum. Therefore we look to external signals. When the Centre Pompidou acquires Block 10 as mentioned earlier, or when artworld’s leading curators like Hans-Ulrich Obrist critically engage with it, those are flashes of recognition that Bitcoin has birthed something worthy of heritage status. These signals indicate that Bitcoin is evolving from a purely financial phenomenon into a broader cultural one. The acquisition of Block 10 marked the first time a fragment of Bitcoin’s code entered a national collection. In France, works that enter the national collection become part of the public domain and are legally inalienable –– they can never be sold or removed. In a country whose modern identity was forged in revolution, the gesture carries its own quiet irony: a technology built to resist authority now preserved by one of the oldest symbols of it. A part of Bitcoin’s genesis code now belongs, permanently, to the people of France –– archived under the same ideals that once demanded the rewriting of history itself. It’s hard to imagine a stronger validation that the Bitcoin narrative has broken out of its early techno-utopian niche and into the broader cultural conversation.
The Centre Pomidou in Paris. Home to the French National Collection of Contemporary Art, which now includes BLOCK 10 from the series, Portraits of a Mind.
Interestingly, this institutional recognition coincides with a growing awareness within the Bitcoin community itself — an appreciation that culture is not peripheral but central to its mission. As Smith observes, “Bitcoiners have something really powerful when it comes to art. They’re on a mission and they’re highly motivated. This isn’t a hobby or something you do on the side. It’s a deeply committed crowd, full of enthusiasm and driven by a genuine desire to make the world better”.
He adds that Bitcoiners are “very culturally and socially engaged and natural storytellers who understand memetics and communication in every possible way”. That, Smith notes, “is what art is about”. Indeed to be a Bitcoiner is to be a collector, not of art, but of UTXOs. The psychology of collecting and especially ownership, runs deeply through the psyche of Bitcoiners.
In short, Bitcoiners have been creating culture all along and the cultural work began long before its memes. The very first act in its history wasn’t financial but symbolic –– Satoshi’s embedding of The Times headline in the genesis block. It was a gesture of record and resistance, the first instance of Bitcoin declaring itself through culture.
Now, as significant wealth accumulates in this community, their taste in art is maturing as well. “Many of them, of course, tend to be younger”, Smith notes, “and younger people usually aren’t all that interested in the art of older generations. That’s nothing new; it’s been that way for centuries. The younger crowd always wants its own art. That’s why art and taste evolve every few generations”.
Over time, he predicts, “Bitcoiners’ growing financial capital will translate into cultural capital”. With Bitcoin’s market value climbing into the trillions and a massive wealth transfer to millennials and Gen Z on the horizon, the future of Bitcoin art indeed looks bright. “The future is very, very bright”, Smith says, “because the younger crowd has all the tailwinds” — referring both to financial means and cultural appetite.
In effect, a new collector base is rising — one that sees Bitcoin not just as an investment, but as a story and identity worth expressing through art.
Making Culture Visible
Because Bitcoin lacks formal cultural institutions of its own, artworks like Block 1 become crucial mirrors. They reflect and externalize the cultural values of the Bitcoin adoption in a form that the wider world can see and evaluate. The Sotheby’s sale forces questions about how we value such an object: Is it its materials and aesthetics, its backstory and conceptual depth, or its significance to a community? In practice, all of these converge to give Block 1 value. That value is cultural and contextual, not merely speculative. As Tad Smith learned during his years as CEO at Sotheby’s, a painting’s price can swing wildly based on intangibles: “a piece of canvas with a certain color of paint on it and a certain artist’s name and a certain year and a certain look, is worth $20 million, and then one right next to it could be worth $2”, a disparity that revealed to him “something inherently cultural that really drives the notion of value”. Bitcoin, often touted as digital gold, similarly derives its value from a cultural consensus, a shared belief in its significance. But that consensus can be hard to perceive directly. Art provides a tangible embodiment of those beliefs. When a Bitcoin-inspired artwork commands attention and a high price, it quantifies a bit of Bitcoin’s cultural impact in a language the art world understands.
Reflecting on this connection, Smith once compared Bitcoin’s evolution to the building of a pyramid — a new financial infrastructure, a new concept for money. “For the first time in human history”, he noted, “it’s digital capital. And to start building a pyramid, you start with a bunch of blocks. On the lower level, you make a great big square, and then you add a slightly smaller one on top, and another on top of that”. He described Portraits of a Mind as “memorials of the foundation layer of the creation of future and modern digital capital. It’s the foundation document, recording the charter of where it all began”. A century from now, he suggested, people will look back to these works to understand how Bitcoin started, “they paint a picture of a moment in time”.
Robert Alice’s exhibition of Portraits of a Mind at the Monnaie de Paris, 29 June to 22 October 2023. Credit: Monnaie de Paris.
Art teaches by being seen. It invites interpretation and dialogue; a work like Block 1 makes people ask questions — about Bitcoin’s earliest days, its philosophy, its community — and it does so beyond the usual venues of conferences or developer meetings. Those engaged in this space understand that securing Bitcoin’s place in history means telling and retelling its story in many forms. Visual art, especially works that can hang in galleries or be studied in art history classrooms, gives that story a tangible presence — externalizing Bitcoin’s narrative and weaving it into the broader fabric of contemporary culture.
Finally, the Sotheby’s event highlights a broader truth: Bitcoin’s maturation isn’t just about technological adoption or financial metrics, but about cultural integration. As Tad Smith puts it, “a life of success and wealth without culture is a pretty unexciting life”. He goes on to suggest that “the sooner you begin to experience culture and understand the beautiful qualities that make being human so incredible — literally a divine gift — the better”.
His point is simple but profound: Bitcoin’s promise lies not only in disrupting finance, but in enriching human experience. Engaging with art is part of that fulfillment. The presence of Block 1 in a venue like Sotheby’s signals that the Bitcoin community, consciously or not, is beginning to heed that message. Bitcoin is developing a cultural memory with artifacts like Block 1 acting as its external vessels.
Bitcoin is stepping out as a subject of cultural heritage, not just economic speculation. This single lot at Sotheby’s carries within it the story of Bitcoin’s birth — lines of code painstakingly inscribed in paint and gold — now acknowledged by some of the highest arbiters of cultural value, institutions whose validation both defines and depends on what culture chooses to recognize.
The sale will be closely watched, as the hammer price will say as much about belief as about value, and about how far Bitcoin’s cultural standing has come. You can’t exactly measure culture, but a number can make its value briefly visible. The fact that Block 1 now shares space with contemporary masters signals that Bitcoin’s presence in the world is no longer invisible to traditional gatekeepers. Emerging from a lineage of artistic experiments and cypherpunk culture, it has become a living, multifaceted phenomenon.
At the end, as a closing note and an invitation: the auction takes place on November 18 at Sotheby’s. You don’t have to bid, but you can look. It costs nothing to follow auctions, visit previews, or walk through museums. That’s how culture becomes understandable: by showing up to see it change.